Valuation: Simcere Pharmaceutical Group Limited

Market Cap 343.68Cr 2.7TCr 311.99Cr 288.21Cr 260.01Cr 490.85Cr 32TCr 509.64Cr 3.47TCr 1.37TCr 17TCr 1.29TCr 1.26TCr 55TCr P/E 2026 *
13.2x
P/E 2027 * 11.3x
Enterprise Value 323.79Cr 2.54TCr 293.94Cr 271.53Cr 244.96Cr 462.45Cr 30TCr 480.15Cr 3.27TCr 1.29TCr 16TCr 1.21TCr 1.19TCr 52TCr EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.87x
Free-Float
33.7%
Yield 2026 *
4.04%
Yield 2027 * 4.59%
1 day-0.47%
1 week-6.25%
Current month+3.55%
1 month-4.72%
3 months-13.51%
6 months-7.73%
Current year-12.28%
1 week 10.33
Extreme 10.33
11.15
1 month 9.86
Extreme 9.86
11.38
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
14.34
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 20/08/2026
Chief Executive Officer 54 25/03/2026
Director of Finance/CFO 55 19/11/2019
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/10/26 Other

Chief Executive Officer

2,00,000 0.0078%
28/10/26 Other

Director

2,00,000 0.0078%
20/08/26 Other

Chairperson

-30,00,000 0.1168%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%-6.25%-24.19%+45.83% 345.35Cr
-1.13%+0.25%+38.06%+140.43% 1,27500Cr
-1.36%-1.21%+42.24%+85.68% 68TCr
-0.59%-0.16%+26.02%+111.76% 52TCr
-0.76%+1.27%+41.98%+71.50% 39TCr
-0.75%-3.62%+54.29%+40.57% 36TCr
-1.83%-0.13%+27.64%+60.13% 31TCr
-1.65%-1.88%+2.00%+35.77% 29TCr
-0.95%-1.57%+35.99%+70.23% 25TCr
+1.60%+0.56%+36.19%+128.48% 21TCr
Average -0.94%-0.12%+28.02%+79.04% 43TCr
Weighted average by Cap. -1.44%+0.76%+35.54%+96.11%

Financials

2026 *2027 *
Net sales 152.36Cr 1.2TCr 138.32Cr 127.77Cr 115.27Cr 217.61Cr 14TCr 225.94Cr 1.54TCr 608.96Cr 7.68TCr 571.66Cr 559.62Cr 24TCr 176.04Cr 1.38TCr 159.81Cr 147.62Cr 133.18Cr 251.42Cr 16TCr 261.05Cr 1.78TCr 703.57Cr 8.88TCr 660.48Cr 646.57Cr 28TCr
Net income 26Cr 201.81Cr 23Cr 22Cr 19Cr 37Cr 2.4TCr 38Cr 259.9Cr 102.8Cr 1.3TCr 96Cr 94Cr 4.1TCr 30Cr 238.58Cr 28Cr 25Cr 23Cr 43Cr 2.84TCr 45Cr 307.25Cr 121.53Cr 1.53TCr 114.08Cr 111.68Cr 4.84TCr
Net Debt -20Cr -156.06Cr -18Cr -17Cr -15Cr -28Cr -1.86TCr -29Cr -200.98Cr -79Cr -1TCr -75Cr -73Cr -3.17TCr -14Cr -110.53Cr -13Cr -12Cr -11Cr -20Cr -1.32TCr -21Cr -142.34Cr -56Cr -710.2Cr -53Cr -52Cr -2.24TCr
Projected Income Statement - Annual - Simcere Pharmaceutical Group Limited
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is an investment holding company primarily engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company mainly operates its business through two segments. The Anti-oncology Business segment is mainly engaged in the research and development, manufacturing, sales and commercialization of anti-oncology pharmaceuticals. The Other Pharmaceutical Business segment is mainly engaged in the research and development, manufacturing, sales and commercialization of pharmaceuticals with focus on the multiple therapeutic areas including neuroscience, autoimmune and anti-infection. The Company is also engaged in providing rendering commercialization service of pharmaceutical products. The Company mainly conducts its business in the domestic market.
Employees
7,064
Date Price Change Volume
17/26/17 HK$10.50 -0.47% 38,83,000
16/26/16 HK$10.55 -0.28% 30,77,000
13/26/13 HK$10.58 -2.85% 23,65,537
12/26/12 HK$10.89 -0.18% 25,00,600
11/26/11 HK$10.91 -1.09% 32,01,000
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Simcere Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
8.924CNY
Average target price
16.58CNY
Spread / Average Target
+85.81%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Simcere Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 2096 Stock